Financings In Brief
GenMark Diagnostics prices $42 million secondary offering. Oxford Immunotec raises $28 million for TB test commercialization efforts. Benvenue Medical gets $25 million for spinal devices. More financings.
GenMark Diagnostics prices $42 million secondary offering. Oxford Immunotec raises $28 million for TB test commercialization efforts. Benvenue Medical gets $25 million for spinal devices. More financings.